GSK to disclose payments in India; local firms head for improved transparency
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline continues to increase transparency across its global operations, unveiling plans to disclose details on payments made to healthcare professionals and organizations in India. GSK's efforts come against a backdrop of generally increased scrutiny in India and internationally over commercial relationships between industry and healthcare professionals.